Early Neurovascular Adaptations in Aging Women

NCT ID: NCT06520982

Last Updated: 2025-11-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

EARLY_PHASE1

Total Enrollment

64 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-09-20

Study Completion Date

2028-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Our goal is to enhance our understanding of early vascular adaptations in aging women with an emphasis on the sympathetic nervous system.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Women Sympathetic Nervous System Aging Blood Flow

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Women

Women will be 18-70 years of age

Group Type OTHER

Norepinephrine

Intervention Type DRUG

Infused intra-arterially in a dose-response fashion

Isoproterenol

Intervention Type DRUG

Infused intra-arterially in a dose-response fashion

Acetylcholine

Intervention Type DRUG

Infused intra-arterially in a dose-response fashion

Nitroprusside

Intervention Type DRUG

Infused intra-arterially in a dose-response fashion

Estrogen

Intervention Type DRUG

Infused intra-arterially

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Norepinephrine

Infused intra-arterially in a dose-response fashion

Intervention Type DRUG

Isoproterenol

Infused intra-arterially in a dose-response fashion

Intervention Type DRUG

Acetylcholine

Infused intra-arterially in a dose-response fashion

Intervention Type DRUG

Nitroprusside

Infused intra-arterially in a dose-response fashion

Intervention Type DRUG

Estrogen

Infused intra-arterially

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Assigned female at birth (AFAB)
* 18-70 years of age

Exclusion Criteria

* Assigned male at birth (AMAB)
* Pregnancy, breastfeeding
* Body mass index ≥30 kg/m2
* Taking medications known to affect metabolic, autonomic, and/or respiratory function
* Oral hormonal contraception in last 6 month
* History of hormone replacement therapy
* History of hyster- or oophor-ectomy
* Current smoking/Nicotine use
* Increased risk of bleeding, pro-coagulant disorders, clotting disorders, anticoagulation therapy
* Chronic disease
* Blood pressure ≥140/90 mmHg
* Communication barriers
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Missouri-Columbia

OTHER

Sponsor Role lead

American Heart Association (AHA)

UNKNOWN

Sponsor Role collaborator

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jacqueline K Limberg, PhD

Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Missouri-Columbia

Columbia, Missouri, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jacqueline K Limberg

Role: CONTACT

573-882-2420

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jacqueline K Limberg, Ph.D.

Role: primary

573-882-2420

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2109189

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Variability in Adrenergic Response
NCT00838695 COMPLETED NA
: Vascular Function in Health and Disease
NCT02966665 RECRUITING PHASE1